Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR-IPC-16008619Phase 4Not yet recruiting
Phase 4 trial of mizoribine in IgA vasculitis nephritis, sponsored by General Hospital of Eastern Military Command. Primary endpoints: Total remission rate, Complete remission rate and 1 more. Planned start Jul 2016; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR-IPC-16008619.